Share Issue in Connection with Employee Share Purchase Program

29. Nov 2021 | 2 min read

Moss, 29 November 2021

Reference is made to the annual general meeting held on 4 May 2021 where a
resolution to grant an authorisation for a share issue in connection with an
employee share purchase program (ESPP) was resolved.

Gentian Diagnostics ASA is pleased to announce that it has decided to conduct a
share issue towards company employees that has applied for shares in the ESPP.
Under the terms of the ESPP, all employees have been given the opportunity to
apply for shares up to a maximum amount of NOK 30,000. The company has decided
to award a 25% discount to the volume weighted average price between 19 November
and 26 November 2021, resulting in a subscription price of NOK 54.49 per share.
More than 50% of the employees have applied for shares for approximately NOK
570,000. Based on the application for shares by the employees, the board has
today resolved to increase the company’s share capital by minimum NOK 0.10 and
maximum NOK 1046.10 by issuing minimum 1 and maximum 10,461 new shares at a
subscription price of 54.49 per shares. The shares will be subscribed for within
10 December 2021.

For further information, please contact:

Njaal Kind
CFO, Gentian Diagnostics
Cell Phone: +47 919 06 525

This information is subject to the disclosure requirements pursuant Oslo Børs
Rule Book II




You may also read

Dec 17, 2021 - Kristin Hart

Financial calendar

Financial calendar for Gentian Diagnostics ASA  

Dec 16, 2021 - Kristin Hart

Completed development of SARS CoV-2 antibody assay

Moss, 16 December 2021 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of innovative and..